Frontlight ResearchEarly access
Trial site
Dana-Farber Cancer Institute (DFCI)
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Ovarian cancer3 trials
- Colorectal cancer2 trials
- Pancreatic cancer2 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- and 2 more
- Phase
- Phase 1/23 trials
- Phase 23 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Active, not recruiting5 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Fujifilm Pharmaceuticals U.S.A., Inc.1 trial
- Gilead Sciences1 trial
- IGM Biosciences, Inc.1 trial
- Pfizer1 trial
- Phanes Therapeutics1 trial
- and 4 more
Running trials
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026